Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies

Legood, R; Gray, A; Wolstenholme, J; Moss, S; (2006) Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies. BMJ (Clinical research ed), 332 (7533). pp. 79-85. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.38698.458866.7C

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/bmj.38698.458866.7C

Abstract

Share

Download

Filename: 79.full.pdf

Licence: Creative Commons: Attribution-Noncommercial 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar